Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-small Cell Carcinoma × binimetinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 39 Carcinoma, Non-Small-Cell Lung 15 Lung Neoplasms 10 Colorectal Neoplasms 10 Neoplasm Metastasis 9 Neoplasms 8 Brain Neoplasms 8 Pancreatic Neoplasms 6 Triple Negative Breast Neoplasms 5 Skin Neoplasms 5 Uveal Melanoma 3 Ovarian Neoplasms 3 Gastrointestinal Stromal Tumors 3 Biliary Tract Neoplasms 3 Thyroid Neoplasms 2 Skin Diseases 2 Recurrence 2 Rectal Neoplasms 2 Neurofibromatosis 1 2 Multiple Myeloma 2 Leukemia, Hairy Cell 2 Hereditary Sensory and Autonomic Neuropathies 2 Hematologic Neoplasms 2 Glioma 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Spinocerebellar Degenerations 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Solid Tumors 1

Interventions

pembrolizumab 1 osimertinib 1 binimetinib 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03991819 2025-12-05

BiniPembro

University Health Network, Toronto

Phase 1 Recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡